Effectiveness and toxicity of lenvatinib in refractory thyroid cancer: Dutch real-life data

Abstract

PFS in our non-trial population was significantly shorter than in the SELECT trial population. In the interpretation of results, differences in the real-life population and the SELECT study population regarding patient characteristics should be taken into account.